about
Prophylaxis and treatment of fungal infections with fluconazole in bone marrow transplant patientsPotential fluconazole-induced carbamazepine toxicityProphylactic Measures During Induction for Acute Myeloid Leukemia.Evaluation of the fungitest kit by using strains from human immunodeficiency virus-infected patients: study of azole drug susceptibility.Candida and oral candidosis: a review.Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.Rapid and sensitive assay for fluconazole which uses gas chromatography with electron capture detectionStandardized susceptibility testing of fluconazole: an international collaborative study.Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections.Azoles and antidepressants: a mini-review of the tolerability of co-administration.The use of antifungal therapy in neonatal intensive care.Biodegradable scleral implant for intravitreal controlled release of fluconazole.Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis.Long-term treatment of a breastfeeding mother with fluconazole-resolved nipple pain caused by yeast: a case study.Effect of prolonged fluconazole treatment on Candida albicans in diffusion chambers implanted into mice.Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage.Systemic drugs in the treatment of dermatophytoses.The costs and consequences of neglected medically necessary oral care.Therapy of Cryptococcal Meningitis in non-HIV-infected Patients.Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis.Cryptococcal infection in AIDS.Effects of fluconazole on the sterol and carbohydrate composition of four species of Candida.Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.Critical Considerations in Anticancer Drug Development and Dosing Strategies: The Past, Present, and Future.Treatment of asymptomatic pulmonary cryptococcosis in immunocompetent hosts with oral fluconazole.Efficacy, safety and toleration of fluconazole suppositories in the treatment of oral candidosis.
P2860
Q28342852-2C695828-A095-49E1-A80F-D050A58B7D1FQ28371958-0807AD52-4A06-4117-A6C6-E341F46E9C88Q30235496-75733BD7-140E-41A9-8B3B-021BC9ED47E8Q33959499-345B26DB-5009-4A6A-8FD4-E22DF0B29B6CQ34318789-8FCEDF04-FC55-4B95-AB53-29B0C80FF6E8Q35115708-C0FA9272-5727-4A8E-B0F2-D1D2B647A8E7Q35867277-982B0DE9-697A-41E1-B193-33D85ACDAB59Q35896738-189EB1CA-99C8-4CA7-819E-A40E27FF9550Q36681749-A542F399-790F-4F8F-B86A-96A9414131ACQ37245969-3AB3D1AC-FC59-4B17-A2A5-5FCCFB957728Q37389855-D61EFC12-46CF-4F79-A671-9FEB635D7908Q37985070-40EC0EB2-5844-4A16-838D-DAB55DEDC7B6Q38556348-09DBD13C-7038-43B1-B223-9346DCEA7D98Q39338659-64A3D4B0-FD8E-45D1-A912-A9A47A979C13Q39451502-D75B66C1-F2D2-4D34-AFF1-DC32FE8B0A1CQ39658166-114337A0-4608-474F-80B8-C443AF36B8D6Q39780336-AB5A91A8-96EE-410D-B205-45AEC18F356BQ40851230-DFBE55F4-18BD-4A62-BE5E-CFF1290ACB92Q41324207-4DC4DCC7-F398-4FA8-A38C-B0764BA413AAQ43413886-7CAB8C39-F074-4C38-A2F2-734FA8120850Q43690816-1AF0FE00-D1CB-4789-8532-DDDB0ED68ADFQ44483636-F632A40B-3468-499C-979B-4BC51FA882E2Q44645052-A6B729B1-F7C5-4707-82E1-7737F15B752AQ45173785-BDDD043A-1712-4612-A77C-220BD9E7F800Q45741613-6F24FC34-7B02-4569-8FF3-307CA2C90E63Q47943868-8BE97453-2E81-4C90-8EE2-D52C9C811A55Q53247853-3F483ACA-4E92-43C3-914C-C58B963E8068Q53927975-20903C0F-EE4D-4146-B3AD-B4CADE752205
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Fluconazole, a new antifungal agent.
@en
Fluconazole, a new antifungal agent.
@nl
type
label
Fluconazole, a new antifungal agent.
@en
Fluconazole, a new antifungal agent.
@nl
prefLabel
Fluconazole, a new antifungal agent.
@en
Fluconazole, a new antifungal agent.
@nl
P1476
Fluconazole, a new antifungal agent.
@en
P2093
Galgiani JN
P304
P356
10.7326/0003-4819-113-3-177
P407
P577
1990-08-01T00:00:00Z